TY - JOUR AU - Kunii, Y. AU - Niwa, S. AU - Hagiwara, Y. AU - Maeda, M. AU - Seitoh, T. AU - Suzuki, T. PY - 2009 DA - 2009// TI - The immunohistochemical expression profile of osteopontin in normal human tissues using two site-specific antibodies reveals a wide distribution of positive cells and extensive expression in the central and peripheral nervous systems JO - Med Mol Morphol VL - 42 UR - https://doi.org/10.1007/s00795-009-0459-6 DO - 10.1007/s00795-009-0459-6 ID - Kunii2009 ER - TY - JOUR AU - Rangaswami, H. AU - Bulbule, A. AU - Kundu, G. C. PY - 2006 DA - 2006// TI - Osteopontin: role in cell signaling and cancer progression JO - Trends Cell Biol VL - 16 UR - https://doi.org/10.1016/j.tcb.2005.12.005 DO - 10.1016/j.tcb.2005.12.005 ID - Rangaswami2006 ER - TY - JOUR AU - Wai, P. Y. AU - Kuo, P. C. PY - 2008 DA - 2008// TI - Osteopontin: regulation in tumor metastasis JO - Cancer Metastasis Rev VL - 27 UR - https://doi.org/10.1007/s10555-007-9104-9 DO - 10.1007/s10555-007-9104-9 ID - Wai2008 ER - TY - JOUR AU - Cho, H. J. AU - Cho, H. J. AU - Kim, H. S. PY - 2009 DA - 2009// TI - Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification JO - Curr Atheroscler Rep VL - 11 UR - https://doi.org/10.1007/s11883-009-0032-8 DO - 10.1007/s11883-009-0032-8 ID - Cho2009 ER - TY - JOUR AU - Sodek, J. AU - Ganss, B. AU - McKee, M. D. PY - 2000 DA - 2000// TI - Osteopontin JO - Crit Rev Oral Biol Med VL - 11 UR - https://doi.org/10.1177/10454411000110030101 DO - 10.1177/10454411000110030101 ID - Sodek2000 ER - TY - JOUR AU - Tuck, A. B. AU - Chambers, A. F. AU - Allan, A. L. PY - 2007 DA - 2007// TI - Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management JO - J Cell Biochem VL - 102 UR - https://doi.org/10.1002/jcb.21520 DO - 10.1002/jcb.21520 ID - Tuck2007 ER - TY - JOUR AU - Weber, G. F. AU - Lett, G. S. AU - Haubein, N. C. PY - 2010 DA - 2010// TI - Osteopontin is a marker for cancer aggressiveness and patient survival JO - Br J Cancer VL - 103 UR - https://doi.org/10.1038/sj.bjc.6605834 DO - 10.1038/sj.bjc.6605834 ID - Weber2010 ER - TY - JOUR AU - Denhardt, D. T. AU - Giachelli, C. M. AU - Rittling, S. R. PY - 2001 DA - 2001// TI - Role of osteopontin in cellular signaling and toxicant injury JO - Annu Rev Pharmacol Toxicol VL - 41 UR - https://doi.org/10.1146/annurev.pharmtox.41.1.723 DO - 10.1146/annurev.pharmtox.41.1.723 ID - Denhardt2001 ER - TY - JOUR AU - Denhardt, D. T. AU - Noda, M. AU - O'Regan, A. W. AU - Pavlin, D. AU - Berman, J. S. PY - 2001 DA - 2001// TI - Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival JO - J Clin Invest VL - 107 UR - https://doi.org/10.1172/JCI12980 DO - 10.1172/JCI12980 ID - Denhardt2001 ER - TY - JOUR AU - Yokosaki, Y. AU - Matsuura, N. AU - Sasaki, T. AU - Murakami, I. AU - Schneider, H. AU - Higashiyama, S. AU - Saitoh, Y. AU - Yamakido, M. AU - Taooka, Y. AU - Sheppard, D. PY - 1999 DA - 1999// TI - The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin JO - J Biol Chem VL - 274 UR - https://doi.org/10.1074/jbc.274.51.36328 DO - 10.1074/jbc.274.51.36328 ID - Yokosaki1999 ER - TY - JOUR AU - Bellahcene, A. AU - Castronovo, V. PY - 1995 DA - 1995// TI - Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer JO - Am J Pathol VL - 146 ID - Bellahcene1995 ER - TY - JOUR AU - Brown, L. F. AU - Papadopoulos-Sergiou, A. AU - Berse, B. AU - Manseau, E. J. AU - Tognazzi, K. AU - Perruzzi, C. A. AU - Dvorak, H. F. AU - Senger, D. R. PY - 1994 DA - 1994// TI - Osteopontin expression and distribution in human carcinomas JO - Am J Pathol VL - 145 ID - Brown1994 ER - TY - JOUR AU - Tuck, A. B. AU - O'Malley, F. P. AU - Singhal, H. AU - Harris, J. F. AU - Tonkin, K. S. AU - Kerkvliet, N. AU - Saad, Z. AU - Doig, G. S. AU - Chambers, A. F. PY - 1998 DA - 1998// TI - Osteopontin expression in a group of lymph node negative breast cancer patients JO - Int J Cancer VL - 79 UR - https://doi.org/3.0.CO;2-3 DO - 3.0.CO;2-3 ID - Tuck1998 ER - TY - JOUR AU - Forootan, S. S. AU - Foster, C. S. AU - Aachi, V. R. AU - Adamson, J. AU - Smith, P. H. AU - Lin, K. AU - Ke, Y. PY - 2006 DA - 2006// TI - Prognostic significance of osteopontin expression in human prostate cancer JO - Int J Cancer VL - 118 UR - https://doi.org/10.1002/ijc.21619 DO - 10.1002/ijc.21619 ID - Forootan2006 ER - TY - JOUR AU - Hotte, S. J. AU - Winquist, E. W. AU - Stitt, L. AU - Wilson, S. M. AU - Chambers, A. F. PY - 2002 DA - 2002// TI - Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma JO - Cancer VL - 95 UR - https://doi.org/10.1002/cncr.10709 DO - 10.1002/cncr.10709 ID - Hotte2002 ER - TY - JOUR AU - Agrawal, D. AU - Chen, T. AU - Irby, R. AU - Quackenbush, J. AU - Chambers, A. F. AU - Szabo, M. AU - Cantor, A. AU - Coppola, D. AU - Yeatman, T. J. PY - 2002 DA - 2002// TI - Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling JO - J Natl Cancer Inst VL - 94 UR - https://doi.org/10.1093/jnci/94.7.513 DO - 10.1093/jnci/94.7.513 ID - Agrawal2002 ER - TY - JOUR AU - Bao, L. H. AU - Sakaguchi, H. AU - Fujimoto, J. AU - Tamaya, T. PY - 2007 DA - 2007// TI - Osteopontin in metastatic lesions as a prognostic marker in ovarian cancers JO - J Biomed Sci VL - 14 UR - https://doi.org/10.1007/s11373-006-9143-1 DO - 10.1007/s11373-006-9143-1 ID - Bao2007 ER - TY - JOUR AU - Imano, M. AU - Satou, T. AU - Itoh, T. AU - Sakai, K. AU - Ishimaru, E. AU - Yasuda, A. AU - Peng, Y. F. AU - Shinkai, M. AU - Akai, F. AU - Yasuda, T. PY - 2009 DA - 2009// TI - Immunohistochemical expression of osteopontin in gastric cancer JO - J Gastrointest Surg VL - 13 UR - https://doi.org/10.1007/s11605-009-0955-y DO - 10.1007/s11605-009-0955-y ID - Imano2009 ER - TY - JOUR AU - Lin, F. AU - Li, Y. AU - Cao, J. AU - Fan, S. AU - Wen, J. AU - Zhu, G. AU - Du, H. AU - Liang, Y. PY - 2011 DA - 2011// TI - Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells JO - Mol Biol Rep VL - 38 UR - https://doi.org/10.1007/s11033-010-0671-4 DO - 10.1007/s11033-010-0671-4 ID - Lin2011 ER - TY - JOUR AU - Ye, Q. H. AU - Qin, L. X. AU - Forgues, M. AU - He, P. AU - Kim, J. W. AU - Peng, A. C. AU - Simon, R. AU - Li, Y. AU - Robles, A. I. AU - Chen, Y. PY - 2003 DA - 2003// TI - Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning JO - Nat Med VL - 9 UR - https://doi.org/10.1038/nm843 DO - 10.1038/nm843 ID - Ye2003 ER - TY - JOUR AU - Chambers, A. F. AU - Wilson, S. M. AU - Kerkvliet, N. AU - O'Malley, F. P. AU - Harris, J. F. AU - Casson, A. G. PY - 1996 DA - 1996// TI - Osteopontin expression in lung cancer JO - Lung Cancer VL - 15 UR - https://doi.org/10.1016/0169-5002(95)00595-1 DO - 10.1016/0169-5002(95)00595-1 ID - Chambers1996 ER - TY - JOUR AU - Zhao, B. AU - Sun, T. AU - Meng, F. AU - Qu, A. AU - Li, C. AU - Shen, H. AU - Jin, Y. AU - Li, W. PY - 2011 DA - 2011// TI - Osteopontin as a potential biomarker of proliferation and invasiveness for lung cancer JO - J Cancer Res Clin Oncol VL - 137 UR - https://doi.org/10.1007/s00432-010-0968-7 DO - 10.1007/s00432-010-0968-7 ID - Zhao2011 ER - TY - JOUR AU - Anborgh, P. H. AU - Mutrie, J. C. AU - Tuck, A. B. AU - Chambers, A. F. PY - 2010 DA - 2010// TI - Role of the metastasis-promoting protein osteopontin in the tumour microenvironment JO - J Cell Mol Med VL - 14 UR - https://doi.org/10.1111/j.1582-4934.2010.01115.x DO - 10.1111/j.1582-4934.2010.01115.x ID - Anborgh2010 ER - TY - JOUR AU - Pietrowska, M. AU - Marczak, L. AU - Polanska, J. AU - Behrendt, K. AU - Nowicka, E. AU - Walaszczyk, A. AU - Chmura, A. AU - Deja, R. AU - Stobiecki, M. AU - Polanski, A. PY - 2009 DA - 2009// TI - Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer JO - J Transl Med VL - 7 UR - https://doi.org/10.1186/1479-5876-7-60 DO - 10.1186/1479-5876-7-60 ID - Pietrowska2009 ER - TY - JOUR AU - Shevde, L. A. AU - Samant, R. S. AU - Paik, J. C. AU - Metge, B. J. AU - Chambers, A. F. AU - Casey, G. AU - Frost, A. R. AU - Welch, D. R. PY - 2006 DA - 2006// TI - Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435 JO - Clin Exp Metastasis VL - 23 UR - https://doi.org/10.1007/s10585-006-9013-2 DO - 10.1007/s10585-006-9013-2 ID - Shevde2006 ER - TY - JOUR AU - Suzuki, M. AU - Mose, E. AU - Galloy, C. AU - Tarin, D. PY - 2007 DA - 2007// TI - Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts JO - Am J Pathol VL - 171 UR - https://doi.org/10.2353/ajpath.2007.070232 DO - 10.2353/ajpath.2007.070232 ID - Suzuki2007 ER - TY - JOUR AU - Chakraborty, G. AU - Jain, S. AU - Patil, T. V. AU - Kundu, G. C. PY - 2008 DA - 2008// TI - Down-regulation of osteopontin attenuates breast tumour progression in vivo JO - J Cell Mol Med VL - 12 UR - https://doi.org/10.1111/j.1582-4934.2008.00263.x DO - 10.1111/j.1582-4934.2008.00263.x ID - Chakraborty2008 ER - TY - JOUR AU - Wang, X. AU - Chao, L. AU - Ma, G. AU - Chen, L. AU - Tian, B. AU - Zang, Y. AU - Sun, J. PY - 2008 DA - 2008// TI - Increased expression of osteopontin in patients with triple-negative breast cancer JO - Eur J Clin Invest VL - 38 UR - https://doi.org/10.1111/j.1365-2362.2008.01956.x DO - 10.1111/j.1365-2362.2008.01956.x ID - Wang2008 ER - TY - JOUR AU - Rodenburg, W. AU - Pennings, J. L. AU - Oostrom, C. T. AU - Roodbergen, M. AU - Kuiper, R. V. AU - Luijten, M. AU - de VA PY - 2010 DA - 2010// TI - Identification of breast cancer biomarkers in transgenic mouse models: A proteomics approach JO - Proteomics Clin Appl VL - 4 UR - https://doi.org/10.1002/prca.200900175 DO - 10.1002/prca.200900175 ID - Rodenburg2010 ER - TY - JOUR AU - Jones, R. A. AU - Campbell, C. I. AU - Gunther, E. J. AU - Chodosh, L. A. AU - Petrik, J. J. AU - Khokha, R. AU - Moorehead, R. A. PY - 2007 DA - 2007// TI - Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1209955 DO - 10.1038/sj.onc.1209955 ID - Jones2007 ER - TY - JOUR AU - Franks, S. E. AU - Campbell, C. I. AU - Barnett, E. F. AU - Siwicky, M. D. AU - Livingstone, J. AU - Cory, S. AU - Moorehead, R. A. PY - 2012 DA - 2012// TI - Transgenic IGF-IR overexpression induces mammary tumors with basal-like characteristics while IGF-IR independent mammary tumors express a claudin-low gene signature JO - Oncogene VL - 31 UR - https://doi.org/10.1038/onc.2011.486 DO - 10.1038/onc.2011.486 ID - Franks2012 ER - TY - JOUR AU - Jones, R. A. AU - Moorehead, R. A. PY - 2008 DA - 2008// TI - The impact of transgenic IGF-IR overexpression on mammary development and tumorigenesis JO - J Mammary Gland Biol Neoplasia VL - 13 UR - https://doi.org/10.1007/s10911-008-9097-1 DO - 10.1007/s10911-008-9097-1 ID - Jones2008 ER - TY - JOUR AU - Jones, R. A. AU - Campbell, C. I. AU - Wood, G. A. AU - Petrik, J. J. AU - Moorehead, R. A. PY - 2009 DA - 2009// TI - Reversibility and recurrence of IGF-IR-induced mammary tumors JO - Oncogene VL - 13 ID - Jones2009 ER - TY - JOUR AU - Campbell, C. I. AU - Thompson, D. E. AU - Siwicky, M. D. AU - Moorehead, R. A. PY - 2011 DA - 2011// TI - Murine mammary tumor cells with a claudin-low genotype JO - Cancer Cell Int VL - 11 UR - https://doi.org/10.1186/1475-2867-11-28 DO - 10.1186/1475-2867-11-28 ID - Campbell2011 ER - TY - JOUR AU - Jones, R. A. AU - Campbell, C. I. AU - Petrik, J. J. AU - Moorehead, R. A. PY - 2008 DA - 2008// TI - Characterization of a novel primary mammary tumor cell line reveals that cyclin D1 is regulated by the type I insulin-like growth factor receptor JO - Mol Cancer Res VL - 6 UR - https://doi.org/10.1158/1541-7786.MCR-07-2157 DO - 10.1158/1541-7786.MCR-07-2157 ID - Jones2008 ER - TY - JOUR AU - Watson, K. L. AU - Stalker, L. AU - Jones, R. A. AU - Moorehead, R. A. PY - 2015 DA - 2015// TI - High levels of dietary soy decrease mammary tumor latency and increase incidence in MTB-IGFIR transgenic mice JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1037-z DO - 10.1186/s12885-015-1037-z ID - Watson2015 ER - TY - JOUR AU - Schneider, C. A. AU - Rasband, W. S. AU - Eliceiri, K. W. PY - 2012 DA - 2012// TI - NIH Image to ImageJ: 25 years of image analysis JO - Nat Methods VL - 9 UR - https://doi.org/10.1038/nmeth.2089 DO - 10.1038/nmeth.2089 ID - Schneider2012 ER - TY - JOUR AU - Thompson, D. E. AU - Siwicky, M. D. AU - Moorehead, R. A. PY - 2012 DA - 2012// TI - Caveolin-1 expression is elevated in claudin-low mammary tumor cells JO - Cancer Cell Int VL - 12 UR - https://doi.org/10.1186/1475-2867-12-6 DO - 10.1186/1475-2867-12-6 ID - Thompson2012 ER - TY - JOUR AU - Campbell, C. I. AU - Moorehead, R. A. PY - 2011 DA - 2011// TI - Mammary tumors that become independent of the type I insulin-like growth factor receptor express elevated levels of platelet-derived growth factor receptors JO - BMC Cancer VL - 11 UR - https://doi.org/10.1186/1471-2407-11-480 DO - 10.1186/1471-2407-11-480 ID - Campbell2011 ER - TY - JOUR AU - Campbell, C. I. AU - Petrik, J. J. AU - Moorehead, R. A. PY - 2010 DA - 2010// TI - ErbB2 enhances mammary tumorigenesis, oncogene-independent recurrence and metastasis in a model of IGF-IR-mediated mammary tumorigenesis JO - Mol Cancer VL - 9 UR - https://doi.org/10.1186/1476-4598-9-235 DO - 10.1186/1476-4598-9-235 ID - Campbell2010 ER - TY - JOUR AU - Herschkowitz, J. I. AU - Zhao, W. AU - Zhang, M. AU - Usary, J. AU - Murrow, G. AU - Edwards, D. AU - Knezevic, J. AU - Greene, S. B. AU - Darr, D. AU - Troester, M. A. PY - 2012 DA - 2012// TI - Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells JO - Proc Natl Acad Sci USA VL - 109 UR - https://doi.org/10.1073/pnas.1018862108 DO - 10.1073/pnas.1018862108 ID - Herschkowitz2012 ER - TY - JOUR AU - Herschkowitz, J. I. AU - Simin, K. AU - Weigman, V. J. AU - Mikaelian, I. AU - Usary, J. AU - Hu, Z. AU - Rasmussen, K. E. AU - Jones, L. P. AU - Assefnia, S. AU - Chandrasekharan, S. PY - 2007 DA - 2007// TI - Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors JO - Genome Biol VL - 8 UR - https://doi.org/10.1186/gb-2007-8-5-r76 DO - 10.1186/gb-2007-8-5-r76 ID - Herschkowitz2007 ER - TY - JOUR AU - Prat, A. AU - Parker, J. S. AU - Karginova, O. AU - Fan, C. AU - Livasy, C. AU - Herschkowitz, J. I. AU - He, X. AU - Perou, C. M. PY - 2010 DA - 2010// TI - Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer JO - Breast Cancer Res VL - 12 UR - https://doi.org/10.1186/bcr2635 DO - 10.1186/bcr2635 ID - Prat2010 ER - TY - JOUR AU - Ribeiro-Silva, A. AU - Costa JP, O. PY - 2008 DA - 2008// TI - Osteopontin expression according to molecular profile of invasive breast cancer: a clinicopathological and immunohistochemical study JO - Int J Biol Markers VL - 23 ID - Ribeiro-Silva2008 ER - TY - JOUR AU - Li, N. Y. AU - Weber, C. E. AU - Mi, Z. AU - Wai, P. Y. AU - Cuevas, B. D. AU - Kuo, P. C. PY - 2013 DA - 2013// TI - Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype JO - J Am Coll Surg VL - 217 UR - https://doi.org/10.1016/j.jamcollsurg.2013.02.025 DO - 10.1016/j.jamcollsurg.2013.02.025 ID - Li2013 ER - TY - JOUR AU - Chu, J. E. AU - Xia, Y. AU - Chin-Yee, B. AU - Goodale, D. AU - Croker, A. K. AU - Allan, A. L. PY - 2014 DA - 2014// TI - Lung-derived factors mediate breast cancer cell migration through CD44 receptor-ligand interactions in a novel ex vivo system for analysis of organ-specific soluble proteins JO - Neoplasia VL - 16 UR - https://doi.org/10.1593/neo.132076 DO - 10.1593/neo.132076 ID - Chu2014 ER - TY - JOUR AU - Yang, L. AU - Wei, L. AU - Zhao, W. AU - Wang, X. AU - Zheng, G. AU - Zheng, M. AU - Song, X. AU - Zuo, W. PY - 2012 DA - 2012// TI - Down-regulation of osteopontin expression by RNA interference affects cell proliferation and chemotherapy sensitivity of breast cancer MDA-MB-231 cells JO - Mol Med Rep VL - 5 ID - Yang2012 ER - TY - JOUR AU - Zhang, H. AU - Guo, M. AU - Chen, J. H. AU - Wang, Z. AU - Du, X. F. AU - Liu, P. X. AU - Li, W. H. PY - 2014 DA - 2014// TI - Osteopontin knockdown inhibits alphav, beta3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway JO - Cell Physiol Biochem VL - 33 UR - https://doi.org/10.1159/000358670 DO - 10.1159/000358670 ID - Zhang2014 ER - TY - JOUR AU - Hahnel, A. AU - Wichmann, H. AU - Kappler, M. AU - Kotzsch, M. AU - Vordermark, D. AU - Taubert, H. AU - Bache, M. PY - 2010 DA - 2010// TI - Effects of osteopontin inhibition on radiosensitivity of MDA-MB-231 breast cancer cells JO - Radiat Oncol VL - 5 UR - https://doi.org/10.1186/1748-717X-5-82 DO - 10.1186/1748-717X-5-82 ID - Hahnel2010 ER - TY - JOUR AU - Lu, J. G. AU - Li, Y. AU - Li, L. AU - Kan, X. PY - 2011 DA - 2011// TI - Overexpression of osteopontin and integrin alphav in laryngeal and hypopharyngeal carcinomas associated with differentiation and metastasis JO - J Cancer Res Clin Oncol VL - 137 UR - https://doi.org/10.1007/s00432-011-1024-y DO - 10.1007/s00432-011-1024-y ID - Lu2011 ER -